The Safety of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Trastuzumab in HER-2/<i>neu</i> Overexpressed/Amplified Breast Cancer - Concepedia

Concepedia

Publication | Open Access

The Safety of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Trastuzumab in HER-2/<i>neu</i> Overexpressed/Amplified Breast Cancer

DOI Full Paper Access

61

Citations

22

References

2008

Year

Chau T. Dang, Monica Fornier, Steven Sugarman, Tiffany A. Troso-Sandoval, Diana Lake, Gabriella D’Andrea, Andrew D. Seidman, Nancy T. Sklarin, Maura N. Dickler, Violante E. Currie,

Journal of Clinical Oncology

Abstract

Dose-dense AC followed by P/T followed by T is feasible and is not likely to increase the incidence of cardiac events compared to established regimens.

References

	Year	Citations

Page 1